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ABSTRACT
OBJECTIVE: To develop a Charlson-like comorbidity index based on clinical 
conditions and weights of the original Charlson comorbidity index.
METHODS: Clinical conditions and weights were adapted from the 
International Classifi cation of Diseases, 10th revision and applied to a single 
hospital admission diagnosis. The study included 3,733 patients over 18 
years of age who were admitted to a public general hospital in the city of 
Rio de Janeiro, southeast Brazil, between Jan 2001 and Jan 2003. The index 
distribution was analyzed by gender, type of admission, blood transfusion, 
intensive care unit admission, age and length of hospital stay. Two logistic 
regression models were developed to predict in-hospital mortality including: 
a) the aforementioned variables and the risk-adjustment index (full model); 
and b) the risk-adjustment index and patient’s age (reduced model).
RESULTS: Of all patients analyzed, 22.3% had risk scores ≥1, and their 
mortality rate was 4.5% (66.0% of them had scores ≥1). Except for gender 
and type of admission, all variables were retained in the logistic regression. 
The models including the developed risk index had an area under the receiver 
operating characteristic curve of 0.86 (full model), and 0.76 (reduced model). 
Each unit increase in the risk score was associated with nearly 50% increase 
in the odds of in-hospital death.
CONCLUSIONS: The risk index developed was able to effectively 
discriminate the odds of in-hospital death which can be useful when limited 
information is available from hospital databases.
DESCRIPTORS: Comorbidity. International Classifi cation of Diseases. 
Hospital Mortality. Medical Records. Models, Statistic. Life Tables. 
Epidemiological Models. Mathematic Models.
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Hospital administrative databases are frequently used 
for estimating clinical or epidemiological empirical 
models and these models should consider, as much as 
possible, the inclusion of variables controlling for pa-
tients’ health status. These variables, known as risk-ad-
justment indexes,21 are also useful for predicting patient 
outcome (e.g., mortality) in a variety of settings.4
One of these indexes is the Charlson Comorbidity In-
dex,3 which essentially classifi es patients by weighting 
the severity of their clinical conditions. The Charlson 
index was originally proposed for longitudinal mortality 
studies, but there is evidence of its validity in a large 
number of clinical situations.7,8 Although the most re-
cent (10th) revision of the International Classifi cation 
of Diseases (ICD) has been available for more than ten 
years,a applications of the Charlson index are frequently 
based on standardized coding of co-morbidities ac-
cording to the ICD, 9th revision (ICD-9).13 In addition, 
the number of conditions to be weighed for a sensitive 
RESUMO
OBJETIVO: Desenvolver um índice de co-morbidade a partir das condições 
clínicas e dos pesos do índice de co-morbidade de Charlson.
MÉTODOS: As condições clínicas e pesos do índice de Charlson foram 
adaptados segundo a Classifi cação Internacional de Doenças – 10a Revisão, e 
aplicados ao diagnóstico principal de internação hospitalar. Foram estudados 
3.733 pacientes acima de 18 anos hospitalizados em hospital geral público 
do município do Rio de Janeiro, RJ, 2001-2003. A distribuição do índice foi 
de acordo com o gênero, tipo da admissão, presença de transfusão de sangue, 
admissão à unidade de terapia intensiva, idade e tempo de internação. Dois 
modelos de regressão logística foram desenvolvidos com o objetivo de prever 
a mortalidade hospitalar desses pacientes: a) com as variáveis acima e o índice 
de co-morbidade (modelo completo); e b) contendo apenas o índice e a idade 
dos pacientes (modelo reduzido).
RESULTADOS: Dentre o total de pacientes analisados, 22,3% possuíam 
escores ≥1 para o índice e sua taxa de mortalidade foi 4,5% (66,0% dos quais 
com escores ≥1). Exceto gênero e do tipo de admissão, todas as variáveis foram 
retidas na regressão. Os modelos tiveram uma área sob a curva característica 
ROC igual a 0,86 (modelo completo) e 0,76 (modelo reduzido). Cada aumento 
de uma unidade nos escores do índice foi associado com um aumento de quase 
50% na probabilidade de mortalidade hospitalar. 
CONCLUSÕES: O índice desenvolvido pôde discriminar probabilidades de 
mortalidade com uma efi cácia aceitável, o que pode ser útil ao lidar-se com 
bancos de dados hospitalares com informação limitada.
DESCRITORES: Comorbidade. Classifi cação Internacional de Doenças. 
Mortalidade Hospitalar. Registros Médicos. Modelos Estatísticos. Tábuas 
de Vida. Modelos Epidemiológicos. Modelos Matemáticos.
INTRODUCTION
a World Health Organization. International Statistical Classifi cation of Diseases and Related Health Problems – 10th Revision. [cited 2007 Jan 
11]. Available from: http://www.who.int/classifi cations/icd/en/,
index is not clear, and, in some countries, detailed and 
reliable records of patient co-morbidities are not even 
available from administrative hospital databases.
The objective of the present study was to assess an 
adapted version of the Charlson index updated for the 
ICD-10 coding scheme.
METHODS
A public general hospital in the city of Rio de Janeiro, 
Southeastern Brazil, was studied. General surgery and 
outpatient treatment were the most prevalent hospital 
services, and no emergency room care was available. 
The 200-bed hospital had a staff of about 1,300 persons 
and provided approximately 12,700 outpatient consulta-
tions a month. The main hospital departments were gen-
eral surgery, internal medicine, cardiology, orthopedics, 
gynecology, thoracic surgery and urology.
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Data were obtained from an information system devel-
oped by the Brazilian Ministry of Health for administra-
tive/reimbursement purposes (Sistema de Informações 
Ambulatoriais do Sistema Único de Saúde – National 
Health System Information System Database, SIA-
SUS). Besides patient data such as age and home 
address, this system includes information concerning 
patients’ admissions in public hospitals, and their main 
admission diagnosis.2 All patients over 18 years of age 
admitted in the hospitals during the period between 
January 2001 and January 2003 were included in the 
analysis (N=3,733).
For the computation of the original Charlson index, 
weights (0, 1, 2, 3 and 6) had to be applied to the pa-
tients’ selected clinical conditions. These weights were 
defi ned according to the relative mortality risks of the 
conditions studied, and were estimated from a cohort 
admitted to two hospitals in the United States.3 The 
clinical conditions of the Charlson index were adapted 
from the ICD-10 codes.23 This adaptation was based on 
the list of clinical conditions and their descriptions,3 
which were translated into the ICD-10 with the help 
of existing Charlson index based on ICD-9 mappings 
and standard medical references.1,5,6,11,17 The codes and 
their respective weights were applied to the patient’s 
main admission diagnosis, yielding a Charlson index-
like risk adjustment index that consisted of a clinical 
condition and its weight.
The index distribution among patients admitted to the 
hospital was analyzed (for each one of the departments 
previously mentioned) by gender, type of admission, 
blood transfusion, intensive care unit admission, age 
and length of hospital stay. These variables, together 
with the developed risk index, were then included in 
two logistic models to predict in-hospital mortality 
for the patients studied. For the fi rst (full) model, all 
aforementioned independent variables were included in 
the regression, and the non-statistically signifi cant ones 
were excluded, yielding a fi nal model with all p-values 
below 0.05. In this fi nal model, variable interactions 
were tested in the usual manner.10 For the second model 
(the reduced one), only patient’s age and the risk-adjust-
ment index were included as predictors. In addition, 
both basic models were replicated with an existing 
alternative ICD-10 Charlson index mapping.22
Gender, type of admission, blood transfusion and 
intensive care unit admission were defi ned as binary 
(male/female or yes/no), age was measured in years 
and length of hospital stay in days. Model goodness-
of-fi t was assessed using the omnibus test for model 
coeffi cients and the c (area under the receiver operating 
characteristic (ROC) curve) statistic.10 The R Software 
was used for data manipulation and analysis.a
RESULTS
Table 1 shows a summary of the clinical conditions 
studied and their coding according to the ICD-10 
mapping developed. In the period studied, 22.3% of 
the patients had their risk-adjustment index equal or 
above 1. Their mortality rate was 4.5% (168 cases), 
and 66% of them had risk-adjustment index scores 
equal or above 1. In 29.2% of the deaths, the main 
diagnosis was malignant neoplasm (score 2); 19.0% 
were primarily diagnosed with congestive heart failure 
and acute myocardial infarction (score 1); 9.5% with 
HIV-related disease (score 6) and 5.4% with chronic 
respiratory diseases (score 1).
Table 2 shows the index scores distribution according 
to hospital departments and selected variables (values 
not presented for cells with less than fi ve patients). 
In general, higher scores were associated with urgent 
admissions, blood transfusions and intensive care unit 
admission. Similarly, score increase was associated 
with an increase in the variables age and length of 
hospital stay. Notably, in the internal medicine depart-
ment, score increases (scores above 2) were associated 
with decreasing age.
For all models, the omnibus test of model coeffi cients 
had a p-value below 0.001. Except for gender and 
type of admission, all independent variables could be 
retained in the full logistic model (Table 3). In this 
model, the c parameter was 0.86 (95% CI: 0.83;0.89), 
intensive care unit admission and blood transfusion 
were the strongest odds predictors and each unit in-
crease in the risk-adjustment score was associated with 
nearly 50% increase in the odds of in-hospital death. 
In the reduced model, both predictors (age and risk-
adjustment index) were statistically signifi cant, and the 
c statistic decreased to 0.76 (95% CI: 0.72;0.80). The 
replicated models with the alternative ICD-10 coding 
had a somewhat poorer performance, with c parameters 
of 0.83 and 0.70, respectively.
DISCUSSION
Table 2 shows that, in general, score increases were 
associated to increased odds of urgent admission, blood 
transfusion, intensive care unit admission and death, 
and increased average age and length of hospital stay. 
The exception to thatwas the internal medicine depart-
ment where care was provided to AIDS patients, who 
accounted for 95% of all cases with risk score ≥3. This 
bias can explain the inconsistency between age and risk 
score found in this department since it is well-known 
that HIV-related diseases usually occur at relatively 
younger ages.
a Vienna University of Economics and Business Administration. The R Project for Statistical Computing. [cited 2007 Jan 11]. Available from: 
<http://www.r-project.org> 
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Table 1. Clinical conditions, CCI-adapted ICD, 10th Revision. Rio de Janeiro, Southeastern Brazil, 2001–2003.
Condition Weight ICD-10 Description
Myocardial infarction 1 I21/I22/I25.2 Acute/Subsequent/Old myocardial infarction
Congestive heart failure 1 I50 Heart failure
Peripheral vascular diseases 1 I71 Aortic aneurysm and dissection
I73 Other peripheral vascular diseases
R02 Gangrene, nec
Z958, Z959 Presence of cardiac and vascular implants and grafts
Cerebrovascular diseases 1 I60-I61 Subarachnoid or intracerebral hemorrhage 
I62 Other nontraumatic intracranial hemorrhage
I63 Cerebral infarction
I64 Stroke, not specifi ed as hemorrhage or infarction
I670 Dissection of cerebral arteries, nonruptured
I676 Nonpyogenic thrombosis of intracranial venous system
I678 Other specifi ed cerebrovascular diseases
I69 Sequelae of cerebrovascular disease
G45 Transient cerebral ischemic attacks and related syndromes
G46 Vascular syndromes of brain in cerebrovascular diseases
Dementia 1 F00-F03/F051 Mental disorders/Delirium superimposed on dementia
Chronic pulmonary disease 1 J40-J47 Chronic lower respiratory diseases
J96.1 Chronic respiratory failure
J84.1 Other interstitial pulmonary diseases with fi brosis
I27.9 Pulmonary heart disease, unspecifi ed
J60-J65 Pneumoconiosis
J66 Airway disease due to specifi c organic dust
J67 Hypersensitivity pneumonitis due to organic dust
J68
Respiratory conditions due to inhalation of chemicals, gases, 
fumes, vapors 
Connective tissue disease 1 L93 Lupus erythematosus
M32 Systemic lupus erythematosus
M33 Dermatopolymyositis
M34 Systemic sclerosis
M05 Infl ammatory polyarthropathies
M06 Other rheumatoid arthritis
M08 Juvenile arthritis
M35.3 Polymyalgia rheumatica
Ulcer disease 1 K25/K26/K27/K28 Gastric/Duodenal/Peptic (site unspecifi ed)/Gastrojejunal ulcer
Mild liver disease 1
K70/K74/K73
Alcoholic liver disease/Fibrosis and cirrhosis of liver/Chronic 
hepatitis nec
Diabetes 1 E10-E14 Diabetes mellitus, excluding subdivisions 2, 3, 4 e 5.
Diabetes w/end organ damage 2 E10-E14 Diabetes mellitus, subdivisions 2, 3, 4 e 5.
Hemiplegia or Paraplegia 2 G81/G82 Hemiplegia/Paraplegia and tetraplegia
Renal disease 2
N01/N03
Rapidly progressive nephritic syndrome/Chronic nephritic 
syndrome
N18/N19 Chronic renal failure/Unspecifi ed renal failure
N25 Disorders from impaired renal tubular function
N052-N056 Unspecifi ed nephritic syndrome
N072-N074 Hereditary nephropathy, nec
Any tumor, including leukemia 
and lymphoma
2 C00-C76 Malignant neoplasms
C80 Malignant neoplasm without specifi cation of site
C81-C97 Malignant neoplasms, stated or presumed to be primary
Moderate or severe liver disease 3 K76.6/I85 Portal hypertension/Esophageal varices
Metastatic solid tumor 6 C77-C79 Secondary and unspecifi ed malignant neoplasm 
AIDS 6 B20, B22-B24 Human immunodefi ciency virus [HIV]
AIDS + Any tumor, including 
leukemia and lymphoma
8 B21 [HIV]-related disease resulting in malignant neoplasms
nec: not elsewhere classifi ed
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Two sets of models were developed for validating the 
newly developed index. Besides a model including clas-
sical predictors of in-hospital mortality, readily avail-
able from administrative databases, a “reduced” model 
was developed allowing better comparability of similar 
studies that sought to predict in-hospital mortality. This 
reduced model included patient’s age, since a variation 
of the Charlson index consists in adding the value “1” 
for every 10 years of life beyond the age of 50.
The widely used area under the ROC curve and its 
derived c parameter were applied to assess model 
performance. In logistic regression (binary classifi er), 
the ROC curve is a plot of false-positive rates (x axis) 
versus true-positive rates (y axis) for many prediction 
thresholds of the model. The c statistic, in turn, is simply 
the area under the curve obtained, so that when c=1 
indicates a perfect classifi er (100% true-positive and 0% 
false-positive rates).10 In the present analysis, however, 
the discriminatory power was lost when a single patient 
diagnosis was used. Thus, the c parameter was 0.86 
for the full model, decreasing to 0.76 when only age 
and risk index were included as mortality predictors. A 
classifi er is usually deemed acceptable with c is above 
0.70 and excellent when c is above 0.80.10
Administrative data are relatively easily available for 
large numbers of patients and thus have been frequently 
used in clinical and epidemiological studies. In this 
sense, having available an index for the evaluation and 
control of patient’s condition severity is a key approach, 
and the Charlson index is one of the most studied in-
dexes.13,14,19,20 Its correlation with costs or odds of death 
has been investigated in both in-hospital and follow-up 
settings. An extensive literature review of 13 comorbid-
ity classifi cation indexes concluded the Charlson index 
was one of the four “(…) valid and reliable methods 
to measure comorbidity that can be used in clinical re-
search”.4 A recent review of studies on Charlson index 
applications can be found in Needham et al 2005.13
However, most applications of this index have been 
described in countries with well-established patient 
recording systems, and in some cases these admin-
istrative databases may contain up to 40 patient ICD 
codes.a But there is little research on the sensitivity of 
risk-adjustment indexes to the number of comorbidities 
used in their construction. In addition, it is well-known 
the quality of comorbidity recording varies widely 
even in countries with well-established hospital data 
collection,12 and, therefore, the extent to which these 
factors actually affect the discriminatory power of the 
index is not clear. In the present study, the database 
also included a secondary admission diagnosis but this 
(non-mandatory) record is usually considered unreli-
able, and this information was missing in about 90% 
of the patients.
As for the translation of clinical conditions into stan-
dardized codes, one of the fi rst attempts to convert the 
clinical conditions described by Charlson3 into ICD 
codes (9th revision) was made in 1992 with Medicare 
claims data (Deyo et al adaptation).5,6 Another adaptation 
was made by the Dartmouth-Manitoba group, resulting 
in an ICD-9 coding scheme that the authors considered 
as“slightly”17 different from the former, and the main 
differences were due to a less rigid interpretation of the 
Charlson index basic clinical conditions.5,6,17,18 Another 
option is the mapping developed by D’Hoore et al,7,8 
which main difference from the previous translations3,5,6 
was the use of three-digit ICD codes. In the present 
study, the Charlson index was adapted from the ICD-
10 disease classifi cation scheme. The ICD-9 has 6,969 
diagnosis codes while the ICD-10 has 12,420 (14,199 
when including Chapter XX – External causes of death). 
The most important changes in the ICD-10 classifi cation 
are the use of alphanumeric codes, the inclusion of B20-
B24 HIV-related codes and more detailed description of 
some conditions, e.g. myocardial infarction codes (six 
codes versus one in the ICD-9).
In the newly developed coding scheme for the ICD-10 
Charlson index representation (Table 1), it should be 
noted that: 1) two-digit codes in this table include all 
corresponding coding subdivisions; 2) HIV-related 
malignant neoplasm (ICD-10 B21) was assigned the 
weight “8” as it includes a condition with weight “2” 
(malignant neoplasm) and another one with weight 
“6”; 3) the weight “2” was assigned to both diabetes 
with end-organ damage – retinopathy, neuropathy, or 
nephropathy – and diabetes mellitus with peripheral 
circulatory complications (E10-14 subdivisions 2, 3, 4 
and 5); and the weight “1” was assigned to the remain-
ing E10-14 codes); 4) following the originally proposed 
Charlson index, i) the ICD-10 code Z-95 presence 
of cardiac and vascular implants and grafts includes 
patients who had bypass for arterial insuffi ciency, ii) 
any tumor, including leukemia and lymphoma includes 
patients with metastatic solid tumors (breast, lung, 
colon, and other tumors), iii) rheumatologic diseases 
includes L93 (lupus erythematosus) and M08 (juvenile 
arthritis), iv) pulmonary disease includes patients with 
or without treatment who are dyspneic with or without 
attacks, represented by the codes J96.1 (chronic respira-
tory failure), J84.1 (other interstitial pulmonary diseases 
with fi brosis), I27.9 (pulmonary heart disease, unspeci-
fi ed) and J68 (respiratory conditions due to inhalation of 
chemicals, gases, fumes, vapors) and v) cerebrovascular 
disease does not include the codes I671, I672, I674, 
a Department of Human Services, Victorian Government. The Victorian Admitted Episodes Dataset, 17th Edition Users Manual. March 18 
2008. Department of Human Services, Health Data Standards and Systems Unit. Victoria, Australia. [cited 2008 Jun 30]. Available from: 
http://www.health.vic.gov.au/hdss/vaed/2007-08/manual/index.htm
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I675, I677 and I679 since only patients with history of 
cerebrovascular accident with minor or no residua and 
transient ischemic attacks are included; 5) following 
Deyo et al adaptation, Alzheimer disease (G30) is not 
included in the dementia category.
Values found for the c parameter in the logistic models 
developed are not different from the results of studies 
with similar applications of the Charlson index or its 
variations. For example, reported c values for Charlson 
index performance in the prediction of in-hospital mor-
tality include either the low 0.64;0.70,9,15 the acceptable 
0.74; 0.769 and the very high 0.83;0.87.7,8,22
In the present study, models including the risk index 
developed had a better performance than those with 
an alternative scheme for the Charlson index ICD-10 
mapping22 (c= 0.76 vs. 0.70 for the reduced model). 
Further studies are required to investigate whether the 
identifi ed predictive advantage is specifi c of the pres-
ent application (that is, the use of a single admission 
diagnosis) or it is a more general characteristic of the 
mapping. The literature has described that only small 
Charlson index performance differences are detectable 
between ICD-9 and ICD-10 revisions.16,22
Ideally, co-morbidities indexes of the Charlson index-
type should be developed for specifi c populations, since 
its weight defi nition is basically cohort-driven.9 This is, 
however, obviously impractical, and a simple, robust 
and reliable (albeit not optimal) index is arguably more 
useful. This is the case of the adaptation proposed in the 
present study, which was able to effectively discrimi-
nate the odds of in-hospital death. The adaptation can 
be a valid approach in settings where limited informa-
tion (single reliable patient diagnosis) is available from 
hospital administrative databases.
Table 3. Logistic regression models for in-hospital patient death. Rio de Janeiro, Southeastern Brazil, 2001–2003.
Model beta p-values OR [95% CI]
ICD-10 developed adaptation 
Full model (c: 0.86; 95% CI [0.83;0.89])
ICU admission 1.44 0.000 4.21 [2.75;6.44]
Blood transfusion 1.57 0.000 4.78 [3.12;7.32]
Age 0.03 0.000 1.03 [1.02;1.04]
Length of hospital stay 0.02 0.000 1.02 [1.01;1.03]
Risk-adjustment index 0.44 0.000 1.56 [1.41;1.72]
Constant -5.58 0.000
Reduced model (c: 0.76; 95% CI [0.72;0.80])
Age 0.03 0.000 1.03 [1.02;1.04]
Risk-adjustment index 0.54 0.000 1.72 [1.58;1.88]
Constant -5.34 0.000
Replicated 
Full model (c: 0.83; 95% CI [0.80;0.87])
ICU admission 1.31 0.000 3.72 [2.44;5.65]
Blood transfusion 1.67 0.000 5.29 [3.48;8.05]
Age 0.02 0.000 1.02 [1.01;1.04]
Length of hospital stay 0.02 0.000 1.02 [1.01;1.03]
Risk-adjustment index 0.30 0.000 1.35 [1.21;1.52]
Constant -5.26 0.000
Reduced model (c: 0.70; 95% CI [0.66;0.74])
Age 0.03 0.000 1.03 [1.02;1.04]
Risk-adjustment index 0.44 0.000 1.56 [1.41;1.72]
Constant -5.03 0.000
P-value for omnibus test of model coeffi cients < 0.001, coeffi cient p-values rounded up to three decimal places
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